TRAF2 Antikörper (N-Term)
Kurzübersicht für TRAF2 Antikörper (N-Term) (ABIN201466)
Target
Alle TRAF2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Recognizes human TRAF2. Species cross-reactivity: mouse and rat.
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide TRAF2 16aa near the amino terminus of human TRAF2 (Genbank accession No. CAI15106).
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: WB (0.5 - 1 μg/mL)
Usage: Suitable for use in Western Blot. Western Blot: 0.5-1 μg/mL. Positive control: Human liver tissue lysate. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.2, 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Short term: 4°C
Long term: Add glycerol (40-50%) -20°C.
-
-
- TRAF2 (TNF Receptor-Associated Factor 2 (TRAF2))
-
Andere Bezeichnung
- TRAP / TRAF2
-
Hintergrund
-
Name/Gene ID: TRAF2
Synonyms: TRAF2, MGC:45012, TRAP3 -
Gen-ID
- 7186
-
UniProt
- Q12933
-
Pathways
- NF-kappaB Signalweg, Apoptose, Caspase Kaskade in der Apoptose, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Positive Regulation of Endopeptidase Activity, Hepatitis C, Unfolded Protein Response, S100 Proteine
Target
-